Deborah Watkins Bruner on Side Effects From Platinum-Based Drugs in Ovarian Cancer

Sap Partners | Schools of Nursing | <b>Nell Hodgson Woodruff School of Nursing at Emory University</b>

Deborah Watkins Bruner, PhD, RN, FAAN, from the Nell Hodgson Woodruff School of Nursing at Emory University, discusses side effects associated with platinum-based drugs for the treatment of ovarian cancer.

Deborah Watkins Bruner, PhD, RN, FAAN, professor, Nell Hodgson Woodruff School of Nursing, Emory University, discusses side effects associated with platinum-based drugs for the treatment of ovarian cancer.

Related Content:

VideosGynecologic CancersAdverse Event Management
Diet and Probiotics Influence Immunotherapy Responses in Melanoma
Olaparib Plus Temozolomide Induces Promising Response Duration in Uterine Leiomyosarcoma
Oral Elacestrant Requires Patient Education in Metastatic ER+ Breast Cancer